TERT and cancer: Across the 141 cross-cancer associations, pleiotropic variants were most commonly found in TERT-CLPTM1L (16% versus 3.0%) and HLA (6p21.32: 16% versus 3.6%; 6p21.33: 13% versus 3.6%).